Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Cancer Type/Condition:  Prostate cancer
Treatment/Intervention:  complementary or alternative medicine procedure
Trial Status:  Active
Results 1-25 of 29 for your search:
Start Over
S0000B: Vitamin E and/or Selenium in Preventing Cataract and Age-Related Macular Degeneration in Men on SELECT SWOG-S0000
Phase: Phase III
Type: Natural history/Epidemiology
Status: Active
Age: 55 and over (50 and over for African Americans)
Sponsor: NCI, Other
Protocol IDs: CDR0000617778, S0000B, U10CA037429, R01EY014418, SWOG-S0000B, NCT00784225
Cholecalciferol Supplement in Treating Patients With Localized Prostate Cancer Undergoing Observation
Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: I 128308, NCI-2009-01530, P30CA016056, RPCI-I-128308, NCT00887432
Managing Cancer and Living Meaningfully (CALM): A Study to Evaluate the Effectiveness of a Psychological Intervention for Cancer Patients
Phase: Phase III
Type: Educational/Counseling/Training, Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: UHN REB 09-0855-C, CIHR, NCT01506492
Effect of Modified Citrus Pectin on PSA Kinetics in Biochemical Relapsed PC With Serial Increases in PSA
Phase: Phase III
Type: Treatment
Status: Active
Age: 21 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: MMC12192-12CTIL, NCT01681823
Acupuncture Treatment for Hot Flashes Study
Phase: Phase II, Phase I
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: NYM # 325, NCT00421902
Calcitriol, Ketoconazole, and Hydrocortisone in Treating Patients With Advanced or Recurrent Prostate Cancer
Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: I 68905, RPCI-I-68905, NCT00536991
Efficacy of FWGE in Combination With Hormone Therapy for the Treatment of Hormone-Refractory Prostate Cancer Patients
Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: SHEBA-06-4232-RW-CTIL, NCT00411853
Use of Organic Germanium or Placebo for the Prevention of Radiation Induced Fatigue
Phase: Phase II
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: Germanium, NCT00651417
Study of Antioxidants on MRI Detectable Early Stage Prostate Cancer Among Men on Active Surveillance
Phase: Phase II
Type: Diagnostic, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 07-0580-B, NCT00744549
Study of Antioxidants on Prostate Tumors in Men Undergoing Radical Prostatectomy for Prostate Cancer
Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 08-0604-CE, NCT00844792
Use of ß-hydroxy-ß-methylbutyrate to Counteract Muscle Loss in Men With Prostate Cancer on Androgen Ablation
Phase: Phase II
Type: Supportive care, Treatment
Status: Active
Age: 65 and over
Sponsor: Other
Protocol IDs: 00016781, NCT01607879
Vitamin D3 Supplementation for Low-Risk Prostate Cancer: A Randomized Trial
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 19 to 90
Sponsor: Other
Protocol IDs: CLIN-007-12S, Pro00019745, NCT01759771
Green Tea Extract in Treating Patients With Low-Risk Prostate Cancer
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 45 to 85
Sponsor: NCI, Other
Protocol IDs: CASE6812, NCI-2013-01372, P30CA043703, NCT01928485
CAPSAICIN Trial: Assessing Capsaicin as a Chemopreventive Agent for Prostate Cancer
Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Status: Approved-not yet active
Age: Over 19
Sponsor: Other
Protocol IDs: 264-2013, NCT02037464
Adjuvant Curcumin to Assess Recurrence Free Survival in Patients Who Have Had a Radical Prostatectomy
Phase: Phase II
Type: Treatment
Status: Active
Age: 18 to 80
Sponsor: Other
Protocol IDs: 042013-080, NCT02064673
High-dose Vitamin D Supplementation for ADT-induced Side Effects
Phase: Phase II
Type: Biomarker/Laboratory analysis, Supportive care
Status: Active
Age: 60 and over
Sponsor: Other
Protocol IDs: 1R21CA175793-01A1, NCT02064946
Pomegranate-Extract Pill in Preventing Tumor Growth in Patients With Localized Prostate Cancer Undergoing Active Surveillance
Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Status: Active
Age: 21 and over
Sponsor: NCI
Protocol IDs: NCI-2014-00695, N01-CN-2012-00033, CO11378, UWI2013-00-01, N01CN00033, N01CN35153, P30CA014520, NCT02095145
Natural Supplements and a Special Diet in Eliminating Cancer-impacting Hormones From Sources Outside the Body in Patients With Early-Stage or Remission Prostate Cancer, Breast Cancer, or Uterine Cancer
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Approved-not yet active
Age: Adult
Sponsor: Other
Protocol IDs: CDR0000643461, BRABANT-00005271, IRB00005271, NCT00910884
Effect of Quercetin on Green Tea Polyphenol Uptake in Prostate Tissue From Patients With Prostate Cancer Undergoing Surgery
Phase: Phase I
Type: Biomarker/Laboratory analysis, Prevention
Status: Active
Age: 40 to 75
Sponsor: NCI, Other
Protocol IDs: 12-000886, NCI-2013-01153, P30CA016042, R03CA171583, NCT01912820
Docetaxel and Lycopene in Metastatic Prostate Cancer
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 101681, 1R21CA166839-01A1, NCT01949519
Effect of CTAP101 Capsules on Ca/iPTH in Advanced Breast/Prostate Cancer Patients Treated With Denosumab/Zoledronic Acid
Phase: Phase I
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CTAP101-CL-1017, NCT02274623
Polyunsaturated Fatty Acids in Treating Patients With Prostate Cancer Undergoing Prostate Biopsy and/or Surgery
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000538993, DFCI-03116, 03-116, NCT00458549
Chemoprevention of Prostate Cancer, HDAC Inhibition and DNA Methylation
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Prevention
Status: Active
Age: 21 and over
Sponsor: NCI, Other
Protocol IDs: Portland VA-09-0607, 2096, 6232, 2PO1CA090890-06A2, NCT01265953
Prostate Cancer Prevention Trial With Quercetin and Genistein
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Prevention
Status: Active
Age: 18 to 65
Sponsor: Other
Protocol IDs: ZEM 21 AII, NCT01538316
Start Over